Relation of vitamin D and vitamin D receptor gene polymorphisms on postmenopausal bone loss

Makoto Owada, Kumiko Suzuki, Satoshi Onogi, Hidekazu Yamada, Susumu Tsukikawa, Kazuhiko Hoshi, Akira Sato

    Research output: Contribution to journalArticlepeer-review


    In order to assess the effect of vitamin D receptor(VDR) gene polymorphisms on vitamin D3 therapy for postmenopausal bone loss. 34 japanease postmenopausal women, administerd vitamin D3 (Alfarol 1.0 n g/day) and Ca (2.0g/day) for 18 months, were analyzed by RFLP method. Bone mineral density(BMD) at the lumber spine (L2-4) and Oscalcis were measured every 6 months by dual energy X-ray absorptiometry (DXA) and single energy X-ray absorptiometry (SXA). VDR-gene allelic polymorphisms were assessed by Bsm 1 endonuclease restriction after specific PCR amplification. Genotypic polymorphism was defined as BB, bb and Bb. The genotypes were BB in 1(3.1%), Bb in 13(40.6%), and bb in 18 (56.3%).The women with these two major VDR genotype groups (Bb and bb) were similar in their backgrounds (terms of age, menopausal age, body mass index, and BMD in premedication). However, VDR genotype was associated with the percent of change of BMD after treatment. In Group-Bb, the mean percent increase in L2-4 BMD were 3.2%, 4.9% and 4.1% at each 6,12 and 18 months. In contrast, in Group-bb were 0.8%, 1.8% and 1.2% at the same points.Analysis of VDR alleles may prove useful in selection of vitamin D therapy for osteopenia before treatment.

    Original languageEnglish
    Pages (from-to)57
    Number of pages1
    JournalJapanese Journal of Human Genetics
    Issue number1
    Publication statusPublished - 1997

    ASJC Scopus subject areas

    • Genetics(clinical)


    Dive into the research topics of 'Relation of vitamin D and vitamin D receptor gene polymorphisms on postmenopausal bone loss'. Together they form a unique fingerprint.

    Cite this